Sook Jin Lee1, Kyung Hee Kim1, Suk Keun Hong1, Shelley Hankins2. 1. Division of Cardiology, Department of Internal Medicine, Sejong General Hospital, 489, 28 Hohyun-ro, Bucheon-shi, Kyungki Province, 14754, South Korea. 2. Division of Cardiology, Drexel University College of Medicine, 245N. 15th street, Philadelphia, PA, 19102, USA. shelley.hankins@drexelmed.edu.
Abstract
PURPOSE OF REVIEW: Heart transplantation is the best option for irreversible and critically advanced heart failure. However, limited donor pool, the risk of rejection, infection, and right ventricular dysfunction in short-term post-transplant period, as well as, the development of coronary allograft vasculopathy and malignancy in the long-term post-transplant period limits the utility of heart transplantation for all comers with advanced heart failure. Therefore, selection of appropriate candidates is very important for the best short and long-term prognosis. In this article, we discuss the principles of selection of candidates and compare to the recently updated International Society for Heart and Lung Transplantation (ISHLT) listing criteria with the goal of updating current clinical practice. RECENT FINDINGS: We found that while most of the recommendations in the new listing criteria are continuous with the previous criteria, updated recommendations are made on the risk stratification models in choosing transplantation candidates. Recommendation on hepatic dysfunction is not directly included in the updated ISHLT listing criteria; however, adoption of the Model for End-stage Liver Disease (MELD) score and modified MELD scores in the evaluation of risk are suggested in recent studies. In conclusion, evaluation of patient selection for heart transplantation should be comprehensive and individualized with respect to indications and the risk of comorbidities of candidates. With the advancement of mechanical circulatory support (MCS), the selection of heart transplantation candidate is continuously evolving and widened. MCS as bridge to candidacy should be considered when the candidate has potentially reversible risk factors for transplantation.
PURPOSE OF REVIEW: Heart transplantation is the best option for irreversible and critically advanced heart failure. However, limited donor pool, the risk of rejection, infection, and right ventricular dysfunction in short-term post-transplant period, as well as, the development of coronary allograft vasculopathy and malignancy in the long-term post-transplant period limits the utility of heart transplantation for all comers with advanced heart failure. Therefore, selection of appropriate candidates is very important for the best short and long-term prognosis. In this article, we discuss the principles of selection of candidates and compare to the recently updated International Society for Heart and Lung Transplantation (ISHLT) listing criteria with the goal of updating current clinical practice. RECENT FINDINGS: We found that while most of the recommendations in the new listing criteria are continuous with the previous criteria, updated recommendations are made on the risk stratification models in choosing transplantation candidates. Recommendation on hepatic dysfunction is not directly included in the updated ISHLT listing criteria; however, adoption of the Model for End-stage Liver Disease (MELD) score and modified MELD scores in the evaluation of risk are suggested in recent studies. In conclusion, evaluation of patient selection for heart transplantation should be comprehensive and individualized with respect to indications and the risk of comorbidities of candidates. With the advancement of mechanical circulatory support (MCS), the selection of heart transplantation candidate is continuously evolving and widened. MCS as bridge to candidacy should be considered when the candidate has potentially reversible risk factors for transplantation.
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff Journal: Circulation Date: 2013-06-05 Impact factor: 29.690
Authors: V M van Deursen; K Damman; H L Hillege; A P van Beek; D J van Veldhuisen; A A Voors Journal: J Card Fail Date: 2009-09-26 Impact factor: 5.712
Authors: Nishant D Patel; Eric S Weiss; Lois U Nwakanma; Stuart D Russell; William A Baumgartner; Ashish S Shah; John V Conte Journal: Circulation Date: 2008-09-30 Impact factor: 29.690
Authors: Sachin Kumar; Salil V Deo; Salah E Altarabsheh; Shannon M Dunlay; Nagaraju Sarabu; Basar Sareyyupoglu; Yakov Elgudin; Benjamin Medalion; Chantal ElAmm; Mahazarin Ginwalla; Michael Zacharias; Rodolpho Benatti; Guilherme H Oliveira; Ahmet Kilic; Gregg C Fonarow; Soon J Park Journal: Am J Cardiol Date: 2016-04-20 Impact factor: 2.778
Authors: Stefan Klotz; Mario C Deng; Dudy Hanafy; Christof Schmid; Jörg Stypmann; Christoph Schmidt; Dieter Hammel; Hans H Scheld Journal: Eur J Heart Fail Date: 2003-10 Impact factor: 15.534
Authors: Bruno Bordoni; Bruno Morabito; Marta Simonelli; Luigi Nicoletti; Riccardo Rinaldi; Filippo Tobbi; Philippe Caiazzo Journal: Int Med Case Rep J Date: 2019-09-05